Page last updated: 2024-11-04

linsidomine and Adenocarcinoma, Basal Cell

linsidomine has been researched along with Adenocarcinoma, Basal Cell in 4 studies

linsidomine: RN given refers to parent cpd; structure

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drapier, JC2
Hirling, H2
Wietzerbin, J2
Kaldy, P2
Kühn, LC2
Invernizzi, P1
Salzman, AL1
Szabó, C1
Ueta, I1
O'Connor, M1
Setchell, KD1
Hara, E1
Takahashi, K1
Takeda, K1
Nakayama, M1
Yoshizawa, M1
Fujita, H1
Shirato, K1
Shibahara, S1

Other Studies

4 other studies available for linsidomine and Adenocarcinoma, Basal Cell

ArticleYear
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.
    The EMBO journal, 1993, Volume: 12, Issue:9

    Topics: Aconitate Hydratase; Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Cells

1993
Reciprocal modulation of aconitase activity and RNA-binding activity of iron regulatory factor by nitric oxide.
    Advances in experimental medicine and biology, 1994, Volume: 356

    Topics: Aconitate Hydratase; Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Inter

1994
Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo.
    The American journal of physiology, 1997, Volume: 273, Issue:1 Pt 1

    Topics: Adenocarcinoma; Animals; Cell Line, Transformed; Cell Survival; Enzyme Induction; Enzyme Repression;

1997
Induction of heme oxygenase-1 as a response in sensing the signals evoked by distinct nitric oxide donors.
    Biochemical pharmacology, 1999, Jul-15, Volume: 58, Issue:2

    Topics: Adenocarcinoma; Colorectal Neoplasms; Drug Synergism; Enzyme Induction; Gene Expression Regulation,

1999